Lycopene And Vitamin E Combination for The Management Of Oral Potentially Malignant Disorders – A Systematic Review
Main Article Content
Keywords
Alpha Tocopherol, Oral precancerous lesion, Tomato extract, Leukoplakia, Lichen Planus, Oral submucous fibrosis
Abstract
Background: Oral potentially malignant disorders (OPMDs) refer to all epithelial lesions and conditions with an increased risk for malignancy. Oral leukoplakia and Oral Submucous Fibrosis are the most common OPMD. Lycopene is a non-provitamin A carotenoid that gives some vegetables and fruits their red color. Vitamin E also called as α-Tocopherol is a non-enzymatic antioxidant. Lycopene and Vitamin E has been proved to be the most potent scavenger of free radicals in various in-vivo and in-vitro studies.
Aim: To assess the effectiveness of lycopene and vitamin E as a combination for the management of Oral Potentially Malignant Disorders.
Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses Guidelines (PRISMA) was followed. The studies included in this systematic review were identified by a comprehensive search from electronic databases until June 2021 using keyword search and MeSH terms. Risk of bias was assessed using RevMan 5 tool.
Results: The search yielded a total of 306 articles out of which 3 articles were included based on the eligibility criteria. From the 3 included studies, a sample size of 182 patients have proven that lycopene and vitamin E combination can be used in the treatment of oral potentially malignant disorders. Among the three clinical trials, one had low risk of bias and other two had intermediate risk of bias. Based on the Oxford Centre for Evidence level, Grade B recommendation is given.
Conclusion: This systematic review highlights the effectiveness of lycopene and vitamin E combination for the management of oral potentially malignant disorders which can be implicated by the practitioners. The average improvement in mouth opening was 6.575 and 91% patients have shown significant improvement in burning sensation. Based on the current evidence, Lycopene and Vitamin E combination could be considered a safe and effective therapeutic modality in the management of Oral Potentially Malignant Disorders.
References
2. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral surgery, oral medicine, oral pathology and oral radiology. 2018 Jun 1;125(6):582-90.
3. Mello FW, Miguel AF, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra EN, Rivero ER. Prevalence of oral potentially malignant disorders: a systematic review and meta‐analysis. Journal of Oral Pathology & Medicine. 2018 Aug;47(7):633-40.
4. Kumar S, Debnath N, Ismail MB, Kumar A, Kumar A, Badiyani BK, Dubey PK, Sukhtankar LV. Prevalence and risk factors for oral potentially malignant disorders in Indian population. Advances in preventive medicine. 2015 Aug 11;2015.
5. Coelho KR. Challenges of the oral cancer burden in India. Journal of cancer epidemiology. 2012 Oct 4;2012.
6. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, Di Maio P, Spriano G, Pardinas Lopez S, Shanti RM. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta‐analysis of malignant transformation rate by subtype. Head & neck. 2020 Mar;42(3):539-55.
7. Nadeau C, Kerr AR. Evaluation and management of oral potentially malignant disorders. Dental Clinics. 2018 Jan 1;62(1):1-27.
8. Islamian JP, Mehrali H. Lycopene as a carotenoid provides radioprotectant and antioxidant effects by quenching radiation-induced free radical singlet oxygen: an overview. Cell Journal (Yakhteh). 2015;16(4):386. 9. Gajowik A, Dobrzynska MM. Lycopene-antioxidant with radioprotective and anticancer properties. A review. Roczniki Państwowego Zakładu Higieny. 2014;65(4).
10. Gupta S, Jawanda MK, Arora V, Mehta N, Yadav V. Role of lycopene in preventing oral diseases as a nonsurgical aid of treatment. International journal of preventive medicine. 2015;6.
11. Trejo-Solís C, Pedraza-Chaverrí J, Torres-Ramos M, Jiménez-Farfán D, Cruz Salgado A, Serrano-García N, Osorio-Rico L, Sotelo J. Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evidence-based complementary and alternative medicine. 2013 Oct;2013.
12. IqubAl MA, KhAn M, KuMAr P, KuMAr A, AjAI K. Role of vitamin E in prevention of oral cancer: - a review. Journal of clinical and diagnostic research: JCDR. 2014 Oct;8(10):ZE05.
13. Rizvi S, Raza ST, Faizal Ahmed AA, Abbas S, Mahdi F. The role of vitamin E in human health and some diseases. Sultan Qaboos University Medical Journal. 2014 May;14(2):e157.
14. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019 Sep 23.
15. Kumar VK, Akshatha LN, Kumaraswamy S, Suhas HG, Topajiche SS. Efficacy of Lycopene in combination with vitamin E in management of OSMF. Journal of Advanced Medical and Dental Sciences Research. 2019 Jun 1;7(6):6-9.
16. Nayak A, Anitha B, Bhattacharya A, Podder S. Efficacy of lycopene in combination with Vitamin E in management of oral submucous fibrosis-A clinical prospective study. Journal of advanced medical and dental sciences research. 2015 Jul 1;3(3):21.
17. Patel JS, Umarji HR, Dhokar AA, Sapkal RB, Patel SG, Panda AK. Randomized controlled trial to evaluate the efficacy of oral lycopene in combination with vitamin E and selenium in the treatment of oral leukoplakia. Journal of Indian Academy of Oral Medicine and Radiology. 2014 Oct 1;26(4):369.
18. Xu Y, Deng X, Sun Y, Wang X, Xiao Y, Li Y, Chen Q, Jiang L. Optical Imaging in the Diagnosis of OPMDs Malignant Transformation. Journal of Dental Research. 2022 Feb 3:00220345211072477.
19. Lee CH, Ko AM, Warnakulasuriya S, Yin BL, Zain RB, Ibrahim SO, Liu ZW, Li WH, Zhang SS, Utomo B, Rajapakse PS. Intercountry prevalences and practices of betel‐quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel‐quid consortium of south and east Asia. International Journal of Cancer. 2011 Oct 1;129(7):1741-51.
20. Rajesh Kashyap R, Shanker Kashyap R. Herbal derivatives in the management of mouth opening in oral submucous fibrosis—A network meta‐analysis. Oral Diseases. 2020 Aug 31.
21. Meroni E, Raikos V. Lycopene in beverage emulsions: optimizing formulation design and processing effects for enhanced delivery. Beverages. 2018 Mar;4(1):14.
22. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. Journal of oral pathology & medicine. 2008 Feb;37(2):63-9.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.